BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 25232231)

  • 1. Potential mechanism of corpus-predominant gastritis after PPI therapy in Helicobacter pylori-positive patients with GERD.
    Mukaisho K; Hagiwara T; Nakayama T; Hattori T; Sugihara H
    World J Gastroenterol; 2014 Sep; 20(34):11962-5. PubMed ID: 25232231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double gastric infection with Helicobacter pylori and non-Helicobacter pylori bacteria during acid-suppressive therapy: increase of pro-inflammatory cytokines and development of atrophic gastritis.
    Sanduleanu S; Jonkers D; De Bruïne A; Hameeteman W; Stockbrügger RW
    Aliment Pharmacol Ther; 2001 Aug; 15(8):1163-75. PubMed ID: 11472319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton pump inhibitors and helicobacter pylori-associated pathogenesis.
    Hagiwara T; Mukaisho K; Nakayama T; Hattori T; Sugihara H
    Asian Pac J Cancer Prev; 2015; 16(4):1315-9. PubMed ID: 25743791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Indications and consequences of Helicobacter pylori eradication on gastroesophageal reflux disease].
    Gisbert JP; Piqué JM
    Med Clin (Barc); 2005 May; 124(18):697-709. PubMed ID: 15899166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori and gastroesophageal reflux disease: friends or foes?
    Gisbert JP; Pajares JM; Losa C
    Hepatogastroenterology; 1999; 46(26):1023-9. PubMed ID: 10370661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Proton Pump Inhibitor on the Distribution of Helicobacter pylori and Associated Gastritis in Patients with Gastric Atrophy.
    Gong EJ; Kim DH; Ahn JY; Na HK; Jung KW; Lee JH; Choi KD; Song HJ; Lee GH; Jung HY; Park Y; Kim MJ
    Digestion; 2020; 101(3):279-286. PubMed ID: 31067538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori, proton pump inhibitors and gastroesophageal reflux disease.
    Kuipers EJ; Klinkenberg-Knol EC; Meuwissen SG
    Yale J Biol Med; 1999; 72(2-3):211-8. PubMed ID: 10780583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale for a Helicobacter pylori Test and Treatment Strategy in Gastroesophageal Reflux Disease.
    Vakil N
    Gastroenterol Clin North Am; 2015 Sep; 44(3):661-6. PubMed ID: 26314675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing patterns of Helicobacter pylori gastritis in long-standing acid suppression.
    Moayyedi P; Wason C; Peacock R; Walan A; Bardhan K; Axon AT; Dixon MF
    Helicobacter; 2000 Dec; 5(4):206-14. PubMed ID: 11179985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of proton pump inhibitors on gastritis diagnosis and pathologic gastric changes.
    Nasser SC; Slim M; Nassif JG; Nasser SM
    World J Gastroenterol; 2015 Apr; 21(15):4599-606. PubMed ID: 25914469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for laryngopharyngeal reflux.
    Saruç M; Aksoy EA; Vardereli E; Karaaslan M; Ciçek B; Ince U; Oz F; Tözün N
    Eur Arch Otorhinolaryngol; 2012 Apr; 269(4):1189-94. PubMed ID: 22207531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic inflammation at the gastroesophageal junction (carditis) appears to be a specific finding related to Helicobacter pylori infection and gastroesophageal reflux disease. The Central Finland Endoscopy Study Group.
    Voutilainen M; Färkkilä M; Mecklin JP; Juhola M; Sipponen P
    Am J Gastroenterol; 1999 Nov; 94(11):3175-80. PubMed ID: 10566710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of corpus gastritis and cagA-positive Helicobacter pylori infection in reflux esophagitis.
    Queiroz DM; Rocha GA; Oliveira CA; Rocha AM; Santos A; Cabral MM; Nogueira AM
    J Clin Microbiol; 2002 Aug; 40(8):2849-53. PubMed ID: 12149341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during 12 months of treatment with omeprazole and lansoprazole in patients with gastro-oesophageal reflux disease.
    Stolte M; Meining A; Schmitz JM; Alexandridis T; Seifert E
    Aliment Pharmacol Ther; 1998 Mar; 12(3):247-53. PubMed ID: 9570259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GERD and H. pylori: is there a link?
    Falk GW
    Semin Gastrointest Dis; 2001 Jan; 12(1):16-25. PubMed ID: 11215851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The possible role of Helicobacter pylori in GERD.
    Falk GW
    Semin Gastrointest Dis; 2001 Jul; 12(3):186-95. PubMed ID: 11478751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interaction of pH, bile, and Helicobacter pylori may explain duodenal ulcer.
    Han SW; Evans DG; el-Zaatari FA; Go MF; Graham DY
    Am J Gastroenterol; 1996 Jun; 91(6):1135-7. PubMed ID: 8651159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with a proton pump inhibitor promotes corpus gastritis in patients with Helicobacter pylori-infected antrum-predominant gastritis.
    Suzuki M; Suzuki H; Kitahora T; Miyazawa M; Nagahashi S; Suzuki K; Ishii H
    Aliment Pharmacol Ther; 2002 Jan; 16(1):159-65. PubMed ID: 11856091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reflux gastritis in gastroesophageal reflux disease: A histopathological study.
    Haber MM; Lopez I
    Ann Diagn Pathol; 1999 Oct; 3(5):281-6. PubMed ID: 10556474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the human gastric microbiota in hypochlorhydric states arising as a result of Helicobacter pylori-induced atrophic gastritis, autoimmune atrophic gastritis and proton pump inhibitor use.
    Parsons BN; Ijaz UZ; D'Amore R; Burkitt MD; Eccles R; Lenzi L; Duckworth CA; Moore AR; Tiszlavicz L; Varro A; Hall N; Pritchard DM
    PLoS Pathog; 2017 Nov; 13(11):e1006653. PubMed ID: 29095917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.